← All organizations

Audentes Therapeutics

For profitWebsite ↗

Also known as: Audentes Therapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Mar 31, 2020

Acquired by Astellas → Leo Pharma on Dec 3, 2019

Timeline

2010s

Jan 1, 2013
Audentes Therapeutics— Founded
Nov 17, 2015
Leo Pharma— Now
Dec 3, 2019
Astellas— Acquired By

Drugs by trial phase (4 distinct, 4 trials)

Phase 2 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (6)

NCT04174105Lead sponsorPhase 1/Phase 2Mar 31, 2020
NCT04240314CollaboratorPhase 1/Phase 2Jan 15, 2020
NCT03223194Study directorPhase 1/Phase 2Sep 8, 2017
NCT03223194Lead sponsorPhase 1/Phase 2Sep 8, 2017
NCT03199469Study directorPhase 1/Phase 2Aug 2, 2017
NCT03199469Lead sponsorPhase 1/Phase 2Aug 2, 2017

Details

Founded: San Francisco, CA, US Jan 1, 2013
Last known activity: Mar 31, 2020